Progress and Challenges in AlGaN/GaN HEMT-Based Bio sensing
AlGaN/GaN HEMTs are emerging as promising biosensors due to their high
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
AlGaN/GaN HEMTs are emerging as promising biosensors due to their high
Prostate cancer is one of the most common malignancies among men worldwide
Colon cancer is a prevalent and potentially deadly disease that can often
BACKGROUND A filled bladder acts as an acoustic window for transabdominal ultrasound
Prostate cancer remains elderly man cancer. It is the most common form
Purpose: It is well-known that indicators such as biopsy and prostatectomy
accuracy of tumor identification, realtime diagnosis, and resection precision through the use of prostate-specific membrane antigen (PSMA) targeting. This paper explores the latest developments in PSMA-targeted surgical…
with 57 cases were diagnosed in 2011. Therefore, early detection is important and prostate-specific antigen (PSA) is widely used as a laboratory test for this purpose. However, despite ... sera were stored at -200C…
with 57 cases were diagnosed in 2011. Therefore, early detection is important and prostate-specific antigen (PSA) is widely used as a laboratory test for this purpose. However, despite ... sera were stored at -200C…
States. The majority of prostate cancer (PCa) detected in the era of routine prostate-specific antigen (PSA) screening are indolent and pose little or no threat to the health
control group. The participants were divided into those CYP17 in the samples. The prostate-specific antigen (PSA) concentrations were also measured in all subjects. When ... control group. The participants were divided…
largely resistant to conventional chemotherapies, and targeted therapies are urgently needed. The PSA (Prostate-Specific Antigen) blood test has been used in various stages of prostate cancer management, including…
quantitative real-time PCR for prostate cancer antigen 3 gene (PCA3) and prostate-specific antigen gene (PSA) expression with the ACTB gene for normalization. PCA3 gene expression was detected
malignancies affecting men. Recurrence of prostate cancer is usually assessed by elevating serum Prostate-Specific Antigen (PSA) level. These days, new radiotracers using Positron Emission Tomography (PET) have…
prostate cancer screening in 1994. Today over four decades have passed since the Prostate-Specific Antigen (PSA) was first discovered. Yet enormous uncertainty governs the effectiveness of PSA testing
cancer) in men at about 20.1 per 100,000 men per year. Serum prostate-specific antigen (PSA) levels may be used to screen men at risk of prostate cancer, while
Controversy surrounds the use of Prostate Specific Antigen (PSA) as a definitive marker for identifying Prostate Cancer (PCa), despite its alarming incidence and mortality rates. This in-depth mini review ... between…
with 57 cases were diagnosed in 2011. Therefore, early detection is important and prostate-specific antigen (PSA) is widely used as a laboratory test for this purpose. However, despite
objective of the present study was to determine the diagnostic accuracy of Prostate specific antigen for the detection of malignancy in breast tumors keeping histopathology as the gold standard. Subjects ... sterile…
Delhi, Kolkata, Nagpur and Thiruvananthpuram), prostate is the second leading site of cancer Prostate-specific antigen (PSA), is elevated in prostate cancer. In 1994, the FDA approved
Delhi, Kolkata, Nagpur and Thiruvananthpuram), prostate is the second leading site of cancer. Prostate-Specific Antigen (PSA), is elevated in prostate cancer. In 1994,PSA levels increase with the increasing
This approach has been used mostly in patients in the presence of defined tumor antigens. Experimental Design: Accessible tumor tissue was disrupted into single cell suspensions. Autologous DCs were prepared ... type 1…
Metastatic prostate cancer is frequently presented as cancer of unknown origin. To
above, with a mortality rate of 71 per 100,000. Early detection through Prostate-Specific Antigen (PSA) screening, though not entirely reliable, remains the most effective method for identifying prostate
Blood samples were collected at baseline, 6 weeks, and 12 weeks to measure Prostate-Specific Antigen (PSA), Matrix Metalloproteinase-9 (MMP-9), Proinflammatory Cytokines
For authors and organisers
Find the right journal for your paper and submit your manuscript.